Meeting the challenge of peripheral arterial disease

Archives of Internal Medicine

Volumn 163, Issue 8, 2003, Pages 877-878

  Halperin, Jonathan L ^a   Fuster, Valentin ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; CHOLESTEROL; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANKLE BRACHIAL INDEX; ATHEROSCLEROSIS; CIGARETTE SMOKING; DIABETES MELLITUS; DIAGNOSTIC TEST; DOPPLER ECHOGRAPHY; EDITORIAL; EXERCISE; GANGRENE; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LEG BLOOD FLOW; LIMB AMPUTATION; PERIPHERAL VASCULAR DISEASE; POPULATION RISK; PRACTICE GUIDELINE; PRESSURE MEASUREMENT; PRIORITY JOURNAL; RISK FACTOR; SMOKING CESSATION; STROKE; VASCULAR DISEASE; ARTERIOSCLEROSIS; MASS SCREENING; NOTE; PERIPHERAL OCCLUSIVE ARTERY DISEASE;

ARTERIAL OCCLUSIVE DISEASES; ARTERIOSCLEROSIS; HUMANS; MASS SCREENING; PERIPHERAL VASCULAR DISEASES; RISK FACTORS;

EID: 0037471557     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.163.8.877     Document Type: Editorial

References (10)

1. Criqui MH, Denenberg JO, Langer RD, Fronek A. The epidemiology of peripheral arterial disease: importance of identifying the population at risk. Vasc Med. 1997; 2:221-226.
2. Dormandy JA, Heeck L, Vig S. The fate of patients with critical leg ischemia. Semin Vasc Surg. 1999;12:142-147.
3. Belch JJF, Topol EJ, Agnelli G, et al, for the Prevention of Atherothrombotic Disease Network. Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med. 2003;163:884-892.
4. Treat-Jacobson D, Regensteiner JG, Creager MA, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001;286: 1317-1324.
5. Dormandy JA, Rutherford RB, for the TransAtlantic Inter-Society Consensus (TASC) Working Group. Management of peripheral arterial disease (PAD). J Vasc Surg. 2000;31 (1, pt 2):S1-S296.
6. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
7. CAPRIE Steering Committee, for the CAPRIE Study Group. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 1996;348:1329-1339.
8. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G, for the Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med. 2000;342:145-153.
9. Hiatt WR, Regensteiner JG, Hargarten ME, Wolfel EE, Brass EP. Benefit of exercise conditioning for patients with peripheral arterial disease. Circulation. 1990; 81:602-609.
10. Beller GA, Bonow RO, Fuster V, for the Core Cardiology Training Symposium (COCATS). ACC revised recommendations for training in adult cardiovascular medicine: Core Cardiology Training II (COCATS 2): (revision of the 1995 COCATS training statement). J Am Coll Cardiol. 2002;39:1242-1246.